Skip to main content

Leica Biosystems News

Updates about Leica Biosystems.


Leica Biosystems’ new R&D facility will serve as a hub for collaborative research with leading pharmaceutical and academic institutions.  The center aims to speed and streamline the development and commercialization of companion diagnostics. NEWCASTLE UPON TYNE, July 23, 2024 – Leica…


Leica Biosystems, a global leader in anatomic pathology, and Navinci, a leader in developing innovative solutions for studying protein interactions, announce a strategic collaboration to drive innovation in cancer patient care. This partnership enables automated in situ proximity ligation assays on…


The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers…